Methods: We investigated the pharmacokinetics of quinine (Qn) following administration of a single oral dose of 600 mg Qn sulphate in six male Thai patients with a moderate degree of chronic renal failure (CRF), and six male Thai subjects with normal renal function. ## Results: The drug was well
β¦ LIBER β¦
Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure
β Scribed by J. R. Kiechel; D. Lavene; M. Guerret; E. Comoy; M. Godin; J. P. Fillastre
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 371 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pharmacokinetics of quinine in patients
β
P. Rimchala; J. Karbwang; K. Sukontason; V. Banmairuroi; P. Molunto; K. Na-Bangc
π
Article
π
1996
π
Springer
π
English
β 521 KB
Pharmacokinetics of mepindolol in patien
β
W. Krause; D. Kampf; H. -Ch. Fischer
π
Article
π
1984
π
Springer
π
English
β 411 KB
Pharmacokinetics of ranitidine in patien
β
M. Lynn McFadyen; P. I. Folb; R. Miller; G. R. Keeton; I. N. Marks
π
Article
π
1983
π
Springer
π
English
β 416 KB
A pharmacokinetic study of prazosin in p
β
N. Lameire; J. Gordts
π
Article
π
1986
π
Springer
π
English
β 527 KB
Pharmacodynamics and pharmacokinetics of
β
H. Kierdorf; A. MΓΌller; P. M. Blanke; J. Gellert; B. Heintz; K. D. RΓ€msch; M. Wa
π
Article
π
1993
π
Springer
π
English
β 656 KB
Nitrendipine solution 5 mg.ml-1 in the dose of 5 mg was given orally to 20 patients with chronic renal failure and elevated diastolic blood pressure (> or = 110 mmHg), of whom 10 were on maintenance haemodialysis (endogenous creatinine clearance < 5 ml.min-1) and 10 were at the predialysis stage (en
Antisecretory effect and oral pharmacoki
β
C. W. Howden; C. D. Payton; P. A. Meredith; D. M. A. Hughes; A. I. Macdougall; J
π
Article
π
1985
π
Springer
π
English
β 435 KB